Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 313 results for "biotechnology regulatory authority of..."

Put info in public domain: Jairam Ramesh on GM mustard
DNA India

Put info in public domain: Jairam Ramesh on GM mustard

Ramesh also expressed regret that independent regulator Biotechnology Regulatory Authority of India is still not in place Business Standard, 1 week ago
Put info in public domain: Ramesh on GM mustard Press Trust of India, 1 week ago
[x]  

253 images for biotechnology regulatory authority of india

Indian Express, 2 days ago
Financial Express, 1 week ago
Indian Express, 5 months ago
The Freepress Journal, 3 hours ago
Financial Express, 2 weeks ago
Financial Express, 2 weeks ago
Pakistan Today, 3 days ago
Indian Express, 2 weeks ago
Times of India, 3 weeks ago
Tech2, 1 week ago

Roche moves court to block copies of cancer drug Avastin, A La Herceptin

MUMBAI: Swiss biotechnology giant Roche has sued the Drug Controller General of India in Delhi High Court along with Hyderabad-based Hetero Drugs over the process followed for approval of copies of complex biotech drugs or biosimilars of Avastin ...
 Economic Times2 months ago
Minyanville

MYLAN NV : and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency

BENGALURU, India, HERTFORDSHIRE, England and PITTSBURGH, July 21, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced today that the European Medicines Agency (EMA) has accepted for review, ...
 4 Traders2 days ago Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency  AndhraNews.net1 day ago Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency  Pharma Focus Asia2 days ago Mylan Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency  India Online.in2 days ago
[x]  
Topco.co.za

SA Pharma still attractive for foreign investors

South Africa may have fallen out of favour with many foreign investors, but Indian investor, Lupin a transnational pharmaceutical company that is currently the7 th largest global generics player and the 5 th largest in the US by prescription still ...
 Cape Business News5 days ago Forget Pharmaceuticals Think Immunology and Synthetic Biology  Master Investor2 weeks ago Indian Government Amends Foreign Direct Investment Policy (July 2016)  Gibson Dunn3 weeks ago
[x]  

First Indian Pharmacovigilance Day conference to be held in Mumbai

Dr J Vijay Venkatraman, MD and CEO, Oviya MedSafe to chair the conference The first Indian Pharmacovigilance Day conference will be held in Mumbai on July 29, 2016. Dr J Vijay Venkatraman, Managing Director and Chief Executive Officer of Oviya ...
 Express Pharma1 day ago Indian Pharmacovigilance Day 2016 to be observed in Mumbai on July 29  PharmaBiz1 month ago

A Clash of IPR Cultures

India's recently released national IPR policy has spurred fresh sparring between various lobbies. As international pressure to fall in line mounts, will Creative India, Innovative India remain a slogan? By Viveka Roychowdhury A few minutes into ...
 Express Pharma2 days ago National IPR Policy announced  Lexology1 month ago A Clash of Intellectual Property Rights Cultures  Financial Express2 weeks ago Finding the Right Balance: International Disputes over Intellectual Property Rights  American Institute for Contemporary German Studies3 weeks ago

Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® Brentuximab Vedotin Monotherapy Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Classical Hodgkin Lymphoma in Blood

Few Sec ago Business Wire India Seattle Genetics, Inc. (NASDAQ:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) announced the final data of the ADCETRIS (brentuximab vedotin) monotherapy pivotal Phase 2 clinical trial in relapsed or ...
 India Online.in5 days ago

ADVATE Now Available in India for the Treatment and Prophylaxis of Hemophilia A

Shire plc announces today the launch of ADVATE (Octocog alfa - Recombinant Coagulation Factor VIII) in India for the treatment and prophylaxis of bleeding in patients with hemophilia A. ADVATE, which came to Shire as part of the recent Baxalta ...
 Pharma Focus Asia1 week ago

India-Africa must join hands to fight food insecurity

Food security continues to be high on the list of development priorities for India and Africa because together, they are home to the largest number of undernourished people in the world. Despite high economic growth rates, India and Africa continue ...
 Observer Research Foundation2 weeks ago

Regulating the regulators

The Supreme Court's decision in end May to mandate a single national entrance exam for UGH and PG medical seats from next year, has merely postponed the debate on medical education. Many state governments, some emboldened by recent poll wins like in ...
 Yahoo! India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biotechnology regulatory authority of india
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less